GE HealthCare Launches AltiX AI.i to Enhance Cardiac Procedures

AngioInsight, Inc. Announces the SMARTFLOW Pivotal Clinical Study

AI-Powered AngioAI+™ Platform to Enhance Cardiovascular Disease Diagnosis, Including Coronary Microvascular Disease (CMD) MINNETONKA, Minn.--(BUSINESS WIRE)--#CMD--AngioInsight, Inc., a leader in AI-driven cardiovascular solutions, today announced the... L'articolo AngioInsight, Inc. Announces the SMARTFLOW Pivotal Clinical Study è un contenuto originale di 01net.

OMSMC enhances care with Cath Lab 2, PRECISE Services

Oriental Melaka Straits Medical Centre launches Cath Lab 2 with Philips Azurion 7, enhancing cardiac care with advanced imaging and PRECISE PGx services. The post OMSMC enhances care with Cath Lab 2, PRECISE Services first appeared on Citizens Journal.

In the Know: Healthcare News for March 17, 2025 - Medical Alley

GE HealthCare expands invasive cardiology solutions portfolio with AltiX AI.i for elevated experience in catheterization lab and electrophysiology proceduresLaplace Interventional raises $22M for tricuspid valve techHumanetics Selects Lifecore Biomedical to Deliver CDMO Services Supporting Development of BIO 300 for the Prevention of Acute Radiation Syndrome ANI Pharmaceuticals Announces FDA Approval for Expansion of ILUVIEN® Label Olympus Annou…

GE HealthCare Expands Invasive Cardiology Product Offerings

AltiX AI.i edition of Mac-Lab, CardioLab and ComboLab can enhance efficiency and precision care for multiple types of cardiac procedures.

GE HealthCare Launches AltiX AI.i to Enhance Cardiac Procedures

What You Should Know:  – GE HealthCare has introduced the AltiX AI.i edition of its Mac-Lab™, CardioLab™, and ComboLab™ systems, designed to elevate cardiac catheterization (cath) lab workflows and support complex electrophysiology (EP) procedures.   – The AltiX AI.i editions include new features aimed at streamlining workflows, enhancing interoperability, and maintaining strong cybersecurity standards.   – The launch comes at a crucial time, as…

HeartLung Technologies to launch AutoChamber™ AI at ACC 2025 and begin offering the AI services to healthcare providers - Journal of Cyber Policy

AutoChamber AI vs MRI for Atrial Fibrillation and Heart Failure HeartLung Technologies to debut its FDA designated “Breakthrough” AI technology (AutoChamber) at ACC 2025, offering lifesaving AI solutions for CVD prevention. HOUSTON, TX, UNITED STATES, March 17, 2025 /EINPresswire.com/ — HeartLung Technologies is thrilled to announce the official launch of AutoChamber at the 2025 American College of Cardiology (ACC) Annual Scientific Session & Ex…